Search research articles
Contact Us
Filters
Showing results (21-30 of 109) with videos related to
Page
of 11
Sort By:
Human Psychopharmacology
|
June 29, 2017
The use of supplements and performance and image enhancing drugs in fitness settings: A exploratory cross-sectional investigation in the United Kingdom
Roisin Mooney, Pierluigi Simonato, Risha Ruparelia, et al.
Substance Use & Misuse
|
May 16, 2014
The diffusion of performance and image-enhancing drugs (PIEDs) on the internet: the abuse of the cognitive enhancer piracetam
Ornella Corazza, Francesco Saverio Bersani, Roberto Brunoro, et al.
Health Education Research
|
February 27, 2026
Evaluating public health campaigns on health promotion, substance use prevention and physical activity: a systematic review
Thomas Zandonai, Giulia Scarpa, Vittoria Barbati, et al.
Human Psychopharmacology
|
July 29, 2015
Psyclones: a roller coaster of life? Hidden synthetic cannabinoids and stimulants in apparently harmless products
Rita Santacroce, Ornella Corazza, Giovanni Martinotti, et al.
Addiction (Abingdon, England)
|
August 26, 2010
Mephedrone, new kid for the chop?
Adam R Winstock, Luke R Mitcheson, Paolo Deluca, et al.
Human Psychopharmacology
|
July 29, 2015
Olanzapine as the ideal "trip terminator"? Analysis of online reports relating to antipsychotics' use and misuse following occurrence of novel psychoactive substance-related psychotic symptoms
Giuseppe Valeriani, Ornella Corazza, Francesco Saverio Bersani, et al.
Biomed Research International
|
July 16, 2014
Sexual enhancement products for sale online: raising awareness of the psychoactive effects of yohimbine, maca, horny goat weed, and Ginkgo biloba
Ornella Corazza, Giovanni Martinotti, Rita Santacroce, et al.
Neuroscience and Biobehavioral Reviews
|
April 7, 2015
Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use
John M Corkery, Barbara Loi, Hugh Claridge, et al.
Journal of Psychoactive Drugs
|
September 5, 2014
"Spice," "kryptonite," "black mamba": an overview of brand names and marketing strategies of novel psychoactive substances on the web
Ornella Corazza, Giuseppe Valeriani, Francesco Saverio Bersani, et al.
Frontiers in Psychology
|
May 12, 2025
The phenomenology of psilocybin: transformative insights for research and clinical practice
Antonio Metastasio, Elisabeth Prevete, Sofia Venturini, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 109) with videos related to
Sort By:
Page
of 11
Human Psychopharmacology
|
June 29, 2017
The use of supplements and performance and image enhancing drugs in fitness settings: A exploratory cross-sectional investigation in the United Kingdom
Roisin Mooney, Pierluigi Simonato, Risha Ruparelia, et al.
Substance Use & Misuse
|
May 16, 2014
The diffusion of performance and image-enhancing drugs (PIEDs) on the internet: the abuse of the cognitive enhancer piracetam
Ornella Corazza, Francesco Saverio Bersani, Roberto Brunoro, et al.
Health Education Research
|
February 27, 2026
Evaluating public health campaigns on health promotion, substance use prevention and physical activity: a systematic review
Thomas Zandonai, Giulia Scarpa, Vittoria Barbati, et al.
Human Psychopharmacology
|
July 29, 2015
Psyclones: a roller coaster of life? Hidden synthetic cannabinoids and stimulants in apparently harmless products
Rita Santacroce, Ornella Corazza, Giovanni Martinotti, et al.
Addiction (Abingdon, England)
|
August 26, 2010
Mephedrone, new kid for the chop?
Adam R Winstock, Luke R Mitcheson, Paolo Deluca, et al.
Human Psychopharmacology
|
July 29, 2015
Olanzapine as the ideal "trip terminator"? Analysis of online reports relating to antipsychotics' use and misuse following occurrence of novel psychoactive substance-related psychotic symptoms
Giuseppe Valeriani, Ornella Corazza, Francesco Saverio Bersani, et al.
Biomed Research International
|
July 16, 2014
Sexual enhancement products for sale online: raising awareness of the psychoactive effects of yohimbine, maca, horny goat weed, and Ginkgo biloba
Ornella Corazza, Giovanni Martinotti, Rita Santacroce, et al.
Neuroscience and Biobehavioral Reviews
|
April 7, 2015
Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use
John M Corkery, Barbara Loi, Hugh Claridge, et al.
Journal of Psychoactive Drugs
|
September 5, 2014
"Spice," "kryptonite," "black mamba": an overview of brand names and marketing strategies of novel psychoactive substances on the web
Ornella Corazza, Giuseppe Valeriani, Francesco Saverio Bersani, et al.
Frontiers in Psychology
|
May 12, 2025
The phenomenology of psilocybin: transformative insights for research and clinical practice
Antonio Metastasio, Elisabeth Prevete, Sofia Venturini, et al.
Page
of 11